|
1
|
Torre LA, Sauer AM, Chen MS Jr,
Kagawa-Singer M, Jemal A and Siegel RL: Cancer statistics for Asian
Americans, Native Hawaiians, and Pacific Islanders, 2016:
Converging incidence in males and females. CA Cancer J Clin.
66:182–202. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen Z, Fillmore CM, Hammerman PS, Kim CF
and Wong KK: Non-small-cell lung cancers: A heterogeneous set of
diseases. Nat Rev Cancer. 14:535–546. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
3
|
Wood SL, Pernemalm M, Crosbie PA and
Whetton AD: The role of the tumor-microenvironment in lung
cancer-metastasis and its relationship to potential therapeutic
targets. Cancer Treat Rev. 40:558–566. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Laskin JJ and Sandler AB: State of the art
in therapy for non-small cell lung cancer. Cancer Invest.
23:427–442. 2005.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lagos-Quintana M, Rauhut R, Lendeckel W
and Tuschl T: Identification of novel genes coding for small
expressed RNAs. Science. 294:853–858. 2001.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Paliouras AR, Monteverde T and Garofalo M:
Oncogene-induced regulation of microRNA expression: Implications
for cancer initiation, progression and therapy. Cancer Lett.
421:152–160. 2018.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ye MF, Zhang JG, Guo TX and Pan XJ:
MiR-504 inhibits cell proliferation and invasion by targeting LOXL2
in non small cell lung cancer. Biomed Pharmacother. 97:1289–1295.
2018.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Hao J, Zhao S, Zhang Y, Zhao Z, Ye R, Wen
J and Li J: Emerging role of microRNAs in cancer and cancer stem
cells. J Cell Biochem. 115:605–610. 2014.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Zhou Q, Huang SX, Zhang F, Li SJ, Liu C,
Xi YY, Wang L, Wang X, He QQ, Sun CC and Li DJ: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50(e12394)2017.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Xiong K, Shao LH, Zhang HQ, Jin L, Wei W,
Dong Z, Zhu YQ, Wu N, Jin SZ and Xue LX: MicroRNA-9 functions as a
tumor suppressor and enhances radio-sensitivity in radio-resistant
A549 cells by targeting neuropilin 1. Oncol Lett. 15:2863–2870.
2018.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhang Y, Wang Y and Wang J: MicroRNA-584
inhibits cell proliferation and invasion in non-small cell lung
cancer by directly targeting MTDH. Exp Ther Med. 15:2203–2211.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kulda V, Svaton M, Mukensnabl P, Hrda K,
Dvorak P, Houdek Z, Houfkova K, Vrzakova R, Babuska V, Pesek M and
Pesta M: Predictive relevance of miR-34a, miR-224 and miR-342 in
patients with advanced squamous cell carcinoma of the lung
undergoing palliative chemotherapy. Oncol Lett. 15:592–599.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zhang J, Wang T, Zhang Y, Wang H, Wu Y,
Liu K and Pei C: Upregulation of serum miR-494 predicts poor
prognosis in non-small cell lung cancer patients. Cancer Biomark.
21:763–768. 2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Cao Q, Mao ZD, Shi YJ, Chen Y, Sun Y,
Zhang Q, Song L and Peng LP: MicroRNA-7 inhibits cell
proliferation, migration and invasion in human non-small cell lung
cancer cells by targeting FAK through ERK/MAPK signaling pathway.
Oncotarget. 7:77468–77481. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Luo J, Li H and Zhang C: MicroRNA-7
inhibits the malignant phenotypes of non-small cell lung cancer in
vitro by targeting Pax6. Mol Med Rep. 12:5443–5448. 2015.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Mou K, Gu W, Gu C, Zhang J, Qwang W, Ren G
and Tian J: Relationship between miR-7 expression and treatment
outcomes with gefitinib in non-small cell lung cancer. Oncol Lett.
12:4613–4617. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Teufel A, Wong EA, Mukhopadhyay M, Malik N
and Westphal H: FoxP4, a novel forkhead transcription factor.
Biochim Biophys Acta. 1627:147–152. 2003.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Tian W, Liu J, Pei B, Wang X, Guo Y and
Yuan L: Identification of miRNAs and differentially expressed genes
in early phase non-small cell lung cancer. Oncol Rep. 35:2171–2176.
2016.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yin Z, Ding H, He E, Chen J and Li M:
Up-regulation of microRNA-491-5p suppresses cell proliferation and
promotes apoptosis by targeting FOXP4 in human osteosarcoma. Cell
Prolif. 50(e12308)2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang G and Sun Y, He Y, Ji C, Hu B and Sun
Y: MicroRNA-338-3p inhibits cell proliferation in hepatocellular
carcinoma by target forkhead box P4 (FOXP4). Int J Clin Exp Pathol.
8:337–344. 2015.PubMed/NCBI
|
|
21
|
Yang T, Li H, Thakur A, Chen T, Xue J, Li
D and Chen M: FOXP4 modulates tumor growth and independently
associates with miR-138 in non-small cell lung cancer cells. Tumour
Biol. 36:8185–8191. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sin C, Li H and Crawford DA:
Transcriptional regulation by FOXP1, FOXP2, and FOXP4 dimerization.
J Mol Neurosci. 55:437–448. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Song XL, Tang Y, Lei XH, Zhao SC and Wu
ZQ: miR-618 inhibits prostate cancer migration and invasion by
targeting FOXP2. J Cancer. 8:2501–2510. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Da C, Liu Y, Zhan Y, Liu K and Wang R:
Nobiletin inhibits epithelial-mesenchymal transition of human
non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3
signaling pathway. Oncol Rep. 35:2767–2774. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Hui Z, Yiling C, Wenting Y, XuQun H,
ChuanYi Z and Hui L: miR-491-5p functions as a tumor suppressor by
targeting JMJD2B in ERα-positive breast cancer. FEBS Lett.
589:812–821. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Xu Y, Hou R, Lu Q, Zhang Y, Chen L, Zheng
Y and Hu B: MiR-491-5p negatively regulates cell proliferation and
motility by targeting PDGFRA in prostate cancer. Am J Cancer Res.
7:2545–2553. 2017.PubMed/NCBI
|
|
28
|
Sun R, Liu Z, Tong D, Yang Y, Guo B, Wang
X, Zhao L and Huang C: miR-491-5p, mediated by Foxi1, functions as
a tumor suppressor by targeting Wnt3a/β-catenin signaling in the
development of gastric cancer. Cell Death Dis.
8(e2714)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Gong F, Ren P, Zhang Y, Jiang J and Zhang
H: MicroRNAs-491-5p suppresses cell proliferation and invasion by
inhibiting IGF2BP1 in non-small cell lung cancer. Am J Transl Res.
8:485–495. 2016.PubMed/NCBI
|
|
30
|
Sun D, Han S, Liu C, Zhou R, Sun W, Zhang
Z and Qu J: Microrna-199a-5p functions as a tumor suppressor via
suppressing connective tissue growth factor (CTGF) in follicular
thyroid carcinoma. Med Sci Monit. 22:1210–1217. 2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Zhang Q, Li Q, Xu T, Jiang H and Xu LG:
miR-491-5p suppresses cell growth and invasion by targeting Notch3
in nasopharyngeal carcinoma. Oncol Rep. 35:3541–3547.
2016.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Pirooz HJ, Jafari N, Rastegari M,
Fathi-Roudsari M, Tasharrofi N, Shokri G, Tamadon M, Sazegar H and
Kouhkan F: Functional SNP in microRNA-491-5p binding site of MMP9
3'-UTR affects cancer susceptibility. J Cell Biochem.
119:5126–5134. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
34
|
Kim S, Lee J, You D, Jeong Y, Jeon M, Yu
J, Kim SW, Nam SJ and Lee JE: Berberine suppresses cell motility
through downregulation of TGF-β1 in triple negative breast cancer
cells. Cell Physiol Biochem. 45:795–807. 2018.PubMed/NCBI View Article : Google Scholar
|
